(Q40785981)

23 September 2017

title

Prospective randomized comparative trial of pefloxacin versus cotrimoxazole in the treatment of typhoid fever in adults (English)

1 reference

23 September 2017

1 reference

M Hajji

1

1 reference

23 September 2017

N el Mdaghri

2

1 reference

23 September 2017

M Benbachir

3

1 reference

23 September 2017

K M el Filali

4

1 reference

23 September 2017

H Himmich

5

1 reference

23 September 2017

publication date

1 June 1988

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

23 September 2017

published in

1 reference

23 September 2017

volume

7

1 reference

23 September 2017

issue

3

1 reference

23 September 2017

page(s)

361-363

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01962337

23 September 2017

exact match

0 references

cites work

Absorption, distribution, metabolic fate, and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys, and humans

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01962337

The diffusion of pefloxacin into bone and the treatment of osteomyelitis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01962337

Pharmacokinetics of pefloxacin after repeated intravenous and oral administration (400 mg bid) in young healthy volunteers

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3137036

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Trimethoprim-sulphamethoxazole in enteric fevers.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3137036

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/BF01962337

1 reference

Dimensions Publication ID

23 September 2017

1048884337

0 references

1 reference